the Web site devoted to the study of the glucagon-like peptides

This Web site is maintained by Dr. Daniel J. Drucker, Mount Sinai Hospital Lunenfeld-Tanenbaum Research Institute   University of Toronto

@DanielJDrucker   EXSCEL Exenatide Once Weekly Top Line Results  REWIND Dulaglutde CVD trial baseline characteristics

Updated overview of GLP-1R agonist Cardiovascular Outcome Studies GLP-1 and the cardiovascular system

Dipeptidyl Peptidase-4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α1-67 in Patients With Type 2 Diabetes